PEPFAR's biggest success is also its largest liability

The Lancet

Volumn 374, Issue 9685, 2009, Pages 184-185

  Navario, Peter ^a  

^a Council on Foreign Relations ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; FUNDING; GOVERNMENT; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; TREATMENT INDICATION; UNITED STATES;

EID: 67650514077     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61312-X     Document Type: Note

References (12)

1. McNeil D.G. After departure, no leader for U.S. AIDS Program. New York Times (Jan 30, 2009). http://www.nytimes.com/2009/01/31/health/31aids.html?scp=1&sq=mark%2 0dybul&st=cse (accessed April 15, 2009).
2. Gerson M. Weasels vs. AIDS relief. Washington Post (Jan 28, 2009). http://www.washingtonpost.com/wp-dyn/content/article/2009/01/27/AR200901 2702673.html (accessed April 15, 2009).
3. Office of the Global AIDS Coordinator. Celebrating life: the U.S. President's Emergency Plan for AIDS Relief: 2009 annual report to Congress (Jan 12, 2009). http://www.pepfar.gov/documents/organization/113827.pdf (accessed April 15, 2009).
4. Rosen S., Fox M.P., and Gill C.J. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4 (2007) e298
5. Weidle P.J., Malamba S., Mwebaze R., et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet 360 (2002) 34-40
6. Stringer J., Zulu I., Levy J., et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296 (2006) 782-793
7. Laurent C., Kouanfack C., Koulla-Shiro S., et al. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet 364 (2004) 29-34
8. Severe P., Leger P., Charles M., et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 353 (2005) 2325-2334
9. Tassie J.-M., Szumilin E., Calmy A., and Goemaere E. Highly active antiretroviral therapy in resource-poor settings: the experience of Médecins Sans Frontières. AIDS 17 (2003) 1995-1996
10. Coetzee D., Hildebrand K., Boulle A., et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18 (2004) 887-895
11. Bekker L.-G., Myer L., Orrell C., Lawn S., and Wood R. Rapid scale-up of a community-based HIV treatment service. S Afr Med J 96 (2006) 315-320
12. Akileswaran C., Lurie M.N., Flanigan T.P., and Mayer K.H. Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis 41 (2005) 376-385